These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37607512)

  • 21. Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (-)-MR22 in rats with selective cholinergic lesion and amyloid infusion.
    Antonini V; Marrazzo A; Kleiner G; Coradazzi M; Ronsisvalle S; Prezzavento O; Ronsisvalle G; Leanza G
    J Alzheimers Dis; 2011; 24(3):569-86. PubMed ID: 21297260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities.
    Walby GD; Martin SF
    Eur J Med Chem; 2022 May; 235():114310. PubMed ID: 35395511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments.
    Maurice T
    Behav Brain Res; 2016 Jan; 296():270-278. PubMed ID: 26386305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.
    Lahmy V; Meunier J; Malmström S; Naert G; Givalois L; Kim SH; Villard V; Vamvakides A; Maurice T
    Neuropsychopharmacology; 2013 Aug; 38(9):1706-23. PubMed ID: 23493042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT
    Wichur T; Pasieka A; Godyń J; Panek D; Góral I; Latacz G; Honkisz-Orzechowska E; Bucki A; Siwek A; Głuch-Lutwin M; Knez D; Brazzolotto X; Gobec S; Kołaczkowski M; Sabate R; Malawska B; Więckowska A
    Eur J Med Chem; 2021 Dec; 225():113783. PubMed ID: 34461507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H
    Szczepańska K; Podlewska S; Dichiara M; Gentile D; Patamia V; Rosier N; Mönnich D; Ruiz Cantero MC; Karcz T; Łażewska D; Siwek A; Pockes S; Cobos EJ; Marrazzo A; Stark H; Rescifina A; Bojarski AJ; Amata E; Kieć-Kononowicz K
    ACS Chem Neurosci; 2022 Jan; 13(1):1-15. PubMed ID: 34908391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
    Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
    Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.
    Sahn JJ; Mejia GL; Ray PR; Martin SF; Price TJ
    ACS Chem Neurosci; 2017 Aug; 8(8):1801-1811. PubMed ID: 28644012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
    Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
    Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin protective effect against amyloid β-induced neurotoxicity mediated by mitochondrial biogenesis; involvement of hippocampal Sirtuin-1 signaling pathway.
    Ansari Dezfouli M; Zahmatkesh M; Farahmandfar M; Khodagholi F
    Physiol Behav; 2019 May; 204():65-75. PubMed ID: 30769106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.
    Zampieri D; Fortuna S; Calabretti A; Romano M; Menegazzi R; Schepmann D; Wünsch B; Collina S; Zanon D; Mamolo MG
    Eur J Med Chem; 2019 Oct; 180():268-282. PubMed ID: 31319263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whether short peptides are good candidates for future neuroprotective therapeutics?
    Perlikowska R
    Peptides; 2021 Jun; 140():170528. PubMed ID: 33716091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo.
    Gunesch S; Hoffmann M; Kiermeier C; Fischer W; Pinto AFM; Maurice T; Maher P; Decker M
    Redox Biol; 2020 Jan; 29():101378. PubMed ID: 31926632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. σ
    Wang H; Peng Z; Li Y; Sahn JJ; Hodges TR; Chou TH; Liu Q; Zhou X; Jiao S; Porciatti V; Liebl DJ; Martin SF; Wen R
    Sci Rep; 2022 Dec; 12(1):20753. PubMed ID: 36456686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.
    Lan Y; Chen Y; Cao X; Zhang J; Wang J; Xu X; Qiu Y; Zhang T; Liu X; Liu BF; Zhang G
    J Med Chem; 2014 Dec; 57(24):10404-23. PubMed ID: 25420090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands.
    Maurice T; Lockhart BP
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):69-102. PubMed ID: 9075259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.
    Linkens K; Schmidt HR; Sahn JJ; Kruse AC; Martin SF
    Eur J Med Chem; 2018 May; 151():557-567. PubMed ID: 29656199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease.
    Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S
    Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.
    Harkany T; Hortobágyi T; Sasvári M; Kónya C; Penke B; Luiten PG; Nyakas C
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):963-1008. PubMed ID: 10621945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.